Orexin A may suppress inflammatory response in fibroblast-like synoviocytes - 20/09/18
pages | 6 |
Iconographies | 9 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | OX1R is expressed in FLSs and increased in RA-FLSs. |
• | TNF-α reduces the expression of OX1R. |
• | Orexin A reduces TNF-α- induced increase in IL-1β, IL-6, IL-8, ROS, MMP-3, and MMP-13. |
• | Orexin A attenuates TNF-α- induced activation of IκBα/NF-κB signaling. |
Abstract |
Orexins are peptides found in the hypothalamus and other peripheral tissues including adipose tissue, the endocrine cells of the gut, adrenal gland testis, and the pancreas. They play important roles in neuro-protection by inhibiting oxidative stress and inflammatory response via their type 1 and 2 receptors (OX1R and OX2R). The expressions of OX1R and OX2R were detected and the physiological function of orexin A in fibroblast-like synoviocytes (FLSs) was investigated in this study. Only OX1R was found on FLSs and the expression of OX1R was decreased in fibroblast-like synoviocytes in rheumatoid arthritis (RA-FLSs) and tumor necrosis factor-α (TNF-α)-treated FLSs. Orexin A exhibited an anti-inflammatory effect on TNF-α treated FLSs. Particularly, orexin A treatment reduced the secretions of interleukin-1β (IL-1β), interleukin-6 (IL-6), and interleukin-8 (IL-8) as well as the production of reactive oxygen species (ROS). Importantly, we showed that orexin A ameliorated the expression of matrix metalloproteinase-3 (MMP-3) and matrix metalloproteinase-13 (MMP-13). Mechanistically, we found that orexin A inhibited TNF-α-induced activation of the nuclear factor-κB (NF-κB) signaling pathway. The current study provides a basis for the potential application of orexin A in the clinical treatment of RA.
Le texte complet de cet article est disponible en PDF.Keywords : Rheumatoid arthritis, Orexin A, Fibroblast-like synoviocytes, TNF-α
Plan
Vol 107
P. 763-768 - novembre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?